Oyende Y, Taus L, Fatatis A
Cancers (Basel). 2025; 17(2).
PMID: 39858071
PMC: 11763358.
DOI: 10.3390/cancers17020290.
Yamaguchi M
Cancers (Basel). 2025; 17(2).
PMID: 39858022
PMC: 11763602.
DOI: 10.3390/cancers17020240.
Waldum H, Slupphaug G
Front Oncol. 2024; 14:1369907.
PMID: 38660133
PMC: 11040596.
DOI: 10.3389/fonc.2024.1369907.
Yamaguchi M
Cancers (Basel). 2023; 15(22).
PMID: 38001749
PMC: 10670417.
DOI: 10.3390/cancers15225489.
Pereira E, de Carvalho M, Nascimento E, Queiroz R, de Almeida A, Antunes A
Asian Pac J Cancer Prev. 2023; 24(9):3087-3097.
PMID: 37774060
PMC: 10762763.
DOI: 10.31557/APJCP.2023.24.9.3087.
Truncation of GalNAc-type O-glycans Suppresses CD44-mediated Osteoclastogenesis and Bone Metastasis in Breast Cancer.
Lin N, Lee J, Chen S, Lin J, Lin C, Lin H
Mol Cancer Res. 2023; 21(7):664-674.
PMID: 37040171
PMC: 10320474.
DOI: 10.1158/1541-7786.MCR-22-0907.
PTHrP induces STAT5 activation, secretory differentiation and accelerates mammary tumor development.
Grinman D, Boras-Granic K, Takyar F, Dann P, Hens J, Marmol C
Breast Cancer Res. 2022; 24(1):30.
PMID: 35440032
PMC: 9020078.
DOI: 10.1186/s13058-022-01523-1.
Genome-wide and transcriptome-wide association studies of mammographic density phenotypes reveal novel loci.
Chen H, Fan S, Stone J, Thompson D, Douglas J, Li S
Breast Cancer Res. 2022; 24(1):27.
PMID: 35414113
PMC: 9006574.
DOI: 10.1186/s13058-022-01524-0.
Circular RNA circIKBKB promotes breast cancer bone metastasis through sustaining NF-κB/bone remodeling factors signaling.
Xu Y, Zhang S, Liao X, Li M, Chen S, Li X
Mol Cancer. 2021; 20(1):98.
PMID: 34325714
PMC: 8320207.
DOI: 10.1186/s12943-021-01394-8.
Inhibition of the Axl pathway impairs breast and prostate cancer metastasis to the bones and bone remodeling.
Tanaka M, Dykes S, Siemann D
Clin Exp Metastasis. 2021; 38(3):321-335.
PMID: 33791875
PMC: 8179919.
DOI: 10.1007/s10585-021-10093-z.
Bone metastasis: evaluation of 1100 patients with breast cancer.
Basdelioglu K
Int J Clin Exp Pathol. 2021; 14(3):338-347.
PMID: 33786150
PMC: 7994145.
Calcium Metabolism and Breast Cancer: Echoes of Lactation?.
Grinman D, Athonvarungkul D, Wysolmerski J, Jeong J
Curr Opin Endocr Metab Res. 2020; 15:63-70.
PMID: 33299957
PMC: 7720883.
DOI: 10.1016/j.coemr.2020.11.006.
Neuroblastoma-secreted exosomes carrying miR-375 promote osteogenic differentiation of bone-marrow mesenchymal stromal cells.
Colletti M, Tomao L, Galardi A, Paolini A, Di Paolo V, De Stefanis C
J Extracell Vesicles. 2020; 9(1):1774144.
PMID: 32922693
PMC: 7448845.
DOI: 10.1080/20013078.2020.1774144.
Adipose Tissue from Lean and Obese Mice Induces a Mesenchymal to Epithelial Transition-Like Effect in Triple Negative Breast Cancers Cells Grown in 3-Dimensional Culture.
Asante E, Pallegar N, Hoffmann A, Viloria-Petit A, Christian S
Int J Mol Sci. 2020; 21(17).
PMID: 32899433
PMC: 7503907.
DOI: 10.3390/ijms21176439.
RANKL/RANK System-Based Mechanism for Breast Cancer Bone Metastasis and Related Therapeutic Strategies.
Wu X, Li F, Dang L, Liang C, Lu A, Zhang G
Front Cell Dev Biol. 2020; 8:76.
PMID: 32117996
PMC: 7026132.
DOI: 10.3389/fcell.2020.00076.
Prediction of Bone Metastasis in Breast Cancer Based on Minimal Driver Gene Set in Gene Dependency Network.
Li J, Zhong R, Zhou X
Genes (Basel). 2019; 10(6).
PMID: 31213036
PMC: 6627827.
DOI: 10.3390/genes10060466.
Inhibition of breast cancer metastasis to the lungs with UBS109.
Shoji M, Qian W, Nagaraju G, Brat D, Pessolano D, Luzietti R
Oncotarget. 2018; 9(90):36102-36109.
PMID: 30546830
PMC: 6281413.
DOI: 10.18632/oncotarget.26302.
Iodine-125 seed implantation combined with arterial chemoembolization therapy for pain palliation in metastatic bone cancer: a retrospective study.
Yang Z, Chen G, Cui Y, Su T, Yu J, Xiao G
Cancer Biol Ther. 2018; 20(2):212-218.
PMID: 30296196
PMC: 6343693.
DOI: 10.1080/15384047.2018.1523847.
Stromal cells in breast cancer as a potential therapeutic target.
Dykes S, Hughes V, Wiggins J, Fasanya H, Tanaka M, Siemann D
Oncotarget. 2018; 9(34):23761-23779.
PMID: 29805773
PMC: 5955086.
DOI: 10.18632/oncotarget.25245.
Evaluation and management of skeletal disease in cancer care.
Kommalapati A, Tella S, Esquivel M, Correa R
Crit Rev Oncol Hematol. 2017; 120:217-226.
PMID: 29032892
PMC: 5773131.
DOI: 10.1016/j.critrevonc.2017.09.003.